Phase II trial of amrubicin for second-line treatment of advanced non-small cell lung cancer: results of the West Japan Thoracic Oncology Group trial (WJTOG0401).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples